WINNIPEG, Manitoba, Jan. 21, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday, January 23, 2025 at 4:15pm Eastern ...
Environmental biotechnology is the branch of biotechnology that addresses environmental problems, such as the removal of pollution, renewable energy generation or biomass production, by exploiting ...
Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
The Bay Area-based biotech revealed the planned IPO in a Jan ... Maze applied to be listed on the Nasdaq under the ticker symbol "MAZE," according to the filing. Analysts predict M&A, IPO uptick ...
Biotechnology contributes to this aspect of the plastics industry while providing end-of-life waste management solutions via enzymatic recycling, facilitating monomer recovery under milder conditions ...
Zhengye Biotechnology (ZYBT) priced its initial public offering of 1.5M shares at a public offering price of $4.00 per share. The shares have been approved for listing on the Nasdaq and are expected ...
Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic ... Shares of Clearmind are listed for trading on Nasdaq under ...
Regeneron, maker of the blockbuster ophthalmology medicine Eylea, has acquired an ocular biotech, the large biopharma confirmed to Endpoints News on Thursday.
2024 was the year of the private megaround. Nine-figure financings dominated biotech’s venture funding landscape, with 96 such rounds tallied by Endpoints News. The bevy … ...
Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...